Great Falls Liberty Dialysis, Llc is a medicare approved dialysis facility center in Great Falls, Montana and it has 18 dialysis stations. It is located in Cascade county at 1724 26th Street S, Great Falls, MT, 59405. You can reach out to the office of Great Falls Liberty Dialysis, Llc at (406) 761-3007. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Great Falls Liberty Dialysis, Llc has the following ownership type - Profit. It was first certified by medicare in January, 2017. The medicare id for this facility is 272512 and it accepts patients under medicare ESRD program.
| Name | Great Falls Liberty Dialysis, Llc |
|---|---|
| Location | 1724 26th Street S, Great Falls, Montana |
| No. of Dialysis Stations | 18 |
| Medicare ID | 272512 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 1724 26th Street S, Great Falls, Montana, 59405 | |
| (406) 761-3007 | |
| Not Available |
News Archive
Today's headlines include reports that the Obama administration plans to tweak the tax-penalty deadline for signing up for health insurance as well as previews of what might happen when the contractors who built the health law's online insurance marketplace testify today on Capitol Hill.
"In 25 countries across Asia, from Kazakhstan to Papua New Guinea, we work to support the success of emerging economies and help address the challenges of hunger and poverty. We do this not just by extending a helping hand, but sharing the hope of the American Dream to people around the world - the mother who eats less so her children can eat more, the girl who risks her life to get an education, the entrepreneur who beats the odds to create a small business that employs his neighbors," Rajiv Shah, USAID administrator, writes in a post on the agency's "Impact blog".
Among patients with diabetes and kidney disease, most receiving an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker, the addition of the medication finerenone compared with placebo resulted in improvement in albuminuria (the presence of excessive protein [chiefly albumin] in the urine), according to a study in the September 1 issue of JAMA.
Findings from clinical trial patients with metastatic renal cell carcinoma, a common kidney cancer, show they did not have accelerated tumor growth after treatment with sunitinib, in contrast to some study results in animals. Sunitinib is one of several drugs, either on the market or undergoing testing, that target blood vessel growth.
› Verified 6 days ago
| NPI Number | 1073975686 |
| Organization Name | Fresenius Medical Care Great Falls Clinic Dialysis |
| Doing Business As | Gfld,llc |
| Address | 1724 26th Street S Great Falls, Montana, 59405 |
| Phone Number | (406) 214-7522 |
News Archive
Today's headlines include reports that the Obama administration plans to tweak the tax-penalty deadline for signing up for health insurance as well as previews of what might happen when the contractors who built the health law's online insurance marketplace testify today on Capitol Hill.
"In 25 countries across Asia, from Kazakhstan to Papua New Guinea, we work to support the success of emerging economies and help address the challenges of hunger and poverty. We do this not just by extending a helping hand, but sharing the hope of the American Dream to people around the world - the mother who eats less so her children can eat more, the girl who risks her life to get an education, the entrepreneur who beats the odds to create a small business that employs his neighbors," Rajiv Shah, USAID administrator, writes in a post on the agency's "Impact blog".
Among patients with diabetes and kidney disease, most receiving an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker, the addition of the medication finerenone compared with placebo resulted in improvement in albuminuria (the presence of excessive protein [chiefly albumin] in the urine), according to a study in the September 1 issue of JAMA.
Findings from clinical trial patients with metastatic renal cell carcinoma, a common kidney cancer, show they did not have accelerated tumor growth after treatment with sunitinib, in contrast to some study results in animals. Sunitinib is one of several drugs, either on the market or undergoing testing, that target blood vessel growth.
› Verified 6 days ago
| Dialysis patients with Hemoglobin data | 8 |
News Archive
Today's headlines include reports that the Obama administration plans to tweak the tax-penalty deadline for signing up for health insurance as well as previews of what might happen when the contractors who built the health law's online insurance marketplace testify today on Capitol Hill.
"In 25 countries across Asia, from Kazakhstan to Papua New Guinea, we work to support the success of emerging economies and help address the challenges of hunger and poverty. We do this not just by extending a helping hand, but sharing the hope of the American Dream to people around the world - the mother who eats less so her children can eat more, the girl who risks her life to get an education, the entrepreneur who beats the odds to create a small business that employs his neighbors," Rajiv Shah, USAID administrator, writes in a post on the agency's "Impact blog".
Among patients with diabetes and kidney disease, most receiving an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker, the addition of the medication finerenone compared with placebo resulted in improvement in albuminuria (the presence of excessive protein [chiefly albumin] in the urine), according to a study in the September 1 issue of JAMA.
Findings from clinical trial patients with metastatic renal cell carcinoma, a common kidney cancer, show they did not have accelerated tumor growth after treatment with sunitinib, in contrast to some study results in animals. Sunitinib is one of several drugs, either on the market or undergoing testing, that target blood vessel growth.
› Verified 6 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 17 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 80 |
| Percentage of adult patients getting regular hemodialysis at the center | 71 |
News Archive
Today's headlines include reports that the Obama administration plans to tweak the tax-penalty deadline for signing up for health insurance as well as previews of what might happen when the contractors who built the health law's online insurance marketplace testify today on Capitol Hill.
"In 25 countries across Asia, from Kazakhstan to Papua New Guinea, we work to support the success of emerging economies and help address the challenges of hunger and poverty. We do this not just by extending a helping hand, but sharing the hope of the American Dream to people around the world - the mother who eats less so her children can eat more, the girl who risks her life to get an education, the entrepreneur who beats the odds to create a small business that employs his neighbors," Rajiv Shah, USAID administrator, writes in a post on the agency's "Impact blog".
Among patients with diabetes and kidney disease, most receiving an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker, the addition of the medication finerenone compared with placebo resulted in improvement in albuminuria (the presence of excessive protein [chiefly albumin] in the urine), according to a study in the September 1 issue of JAMA.
Findings from clinical trial patients with metastatic renal cell carcinoma, a common kidney cancer, show they did not have accelerated tumor growth after treatment with sunitinib, in contrast to some study results in animals. Sunitinib is one of several drugs, either on the market or undergoing testing, that target blood vessel growth.
› Verified 6 days ago
| Adult patients getting regular peritoneal dialysis at the center | 6 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 31 |
News Archive
Today's headlines include reports that the Obama administration plans to tweak the tax-penalty deadline for signing up for health insurance as well as previews of what might happen when the contractors who built the health law's online insurance marketplace testify today on Capitol Hill.
"In 25 countries across Asia, from Kazakhstan to Papua New Guinea, we work to support the success of emerging economies and help address the challenges of hunger and poverty. We do this not just by extending a helping hand, but sharing the hope of the American Dream to people around the world - the mother who eats less so her children can eat more, the girl who risks her life to get an education, the entrepreneur who beats the odds to create a small business that employs his neighbors," Rajiv Shah, USAID administrator, writes in a post on the agency's "Impact blog".
Among patients with diabetes and kidney disease, most receiving an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker, the addition of the medication finerenone compared with placebo resulted in improvement in albuminuria (the presence of excessive protein [chiefly albumin] in the urine), according to a study in the September 1 issue of JAMA.
Findings from clinical trial patients with metastatic renal cell carcinoma, a common kidney cancer, show they did not have accelerated tumor growth after treatment with sunitinib, in contrast to some study results in animals. Sunitinib is one of several drugs, either on the market or undergoing testing, that target blood vessel growth.
› Verified 6 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Great Falls Liberty Dialysis, Llc with elevated calcium levels.
| Patients with hypercalcemia | 24 |
| Hypercalcemia patient months | 120 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 2 |
| Patients with Serumphosphor | 30 |
| Patients with Serumphosphor less than 3.5 mg/dL | 11 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 29 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 27 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 19 |
| Patients with Serumphosphor greater than 7 mg/dL | 15 |
News Archive
Today's headlines include reports that the Obama administration plans to tweak the tax-penalty deadline for signing up for health insurance as well as previews of what might happen when the contractors who built the health law's online insurance marketplace testify today on Capitol Hill.
"In 25 countries across Asia, from Kazakhstan to Papua New Guinea, we work to support the success of emerging economies and help address the challenges of hunger and poverty. We do this not just by extending a helping hand, but sharing the hope of the American Dream to people around the world - the mother who eats less so her children can eat more, the girl who risks her life to get an education, the entrepreneur who beats the odds to create a small business that employs his neighbors," Rajiv Shah, USAID administrator, writes in a post on the agency's "Impact blog".
Among patients with diabetes and kidney disease, most receiving an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker, the addition of the medication finerenone compared with placebo resulted in improvement in albuminuria (the presence of excessive protein [chiefly albumin] in the urine), according to a study in the September 1 issue of JAMA.
Findings from clinical trial patients with metastatic renal cell carcinoma, a common kidney cancer, show they did not have accelerated tumor growth after treatment with sunitinib, in contrast to some study results in animals. Sunitinib is one of several drugs, either on the market or undergoing testing, that target blood vessel growth.
› Verified 6 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 20 |
| Patient months included in arterial venous fistula and catheter summaries | 86 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 34 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 26 |
News Archive
Today's headlines include reports that the Obama administration plans to tweak the tax-penalty deadline for signing up for health insurance as well as previews of what might happen when the contractors who built the health law's online insurance marketplace testify today on Capitol Hill.
"In 25 countries across Asia, from Kazakhstan to Papua New Guinea, we work to support the success of emerging economies and help address the challenges of hunger and poverty. We do this not just by extending a helping hand, but sharing the hope of the American Dream to people around the world - the mother who eats less so her children can eat more, the girl who risks her life to get an education, the entrepreneur who beats the odds to create a small business that employs his neighbors," Rajiv Shah, USAID administrator, writes in a post on the agency's "Impact blog".
Among patients with diabetes and kidney disease, most receiving an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker, the addition of the medication finerenone compared with placebo resulted in improvement in albuminuria (the presence of excessive protein [chiefly albumin] in the urine), according to a study in the September 1 issue of JAMA.
Findings from clinical trial patients with metastatic renal cell carcinoma, a common kidney cancer, show they did not have accelerated tumor growth after treatment with sunitinib, in contrast to some study results in animals. Sunitinib is one of several drugs, either on the market or undergoing testing, that target blood vessel growth.
› Verified 6 days ago
Great Falls Liberty Dialysis, Llc Location: 1724 26th Street S, Great Falls, Montana, 59405 Phone: (406) 761-3007 |
News Archive
Today's headlines include reports that the Obama administration plans to tweak the tax-penalty deadline for signing up for health insurance as well as previews of what might happen when the contractors who built the health law's online insurance marketplace testify today on Capitol Hill.
"In 25 countries across Asia, from Kazakhstan to Papua New Guinea, we work to support the success of emerging economies and help address the challenges of hunger and poverty. We do this not just by extending a helping hand, but sharing the hope of the American Dream to people around the world - the mother who eats less so her children can eat more, the girl who risks her life to get an education, the entrepreneur who beats the odds to create a small business that employs his neighbors," Rajiv Shah, USAID administrator, writes in a post on the agency's "Impact blog".
Among patients with diabetes and kidney disease, most receiving an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker, the addition of the medication finerenone compared with placebo resulted in improvement in albuminuria (the presence of excessive protein [chiefly albumin] in the urine), according to a study in the September 1 issue of JAMA.
Findings from clinical trial patients with metastatic renal cell carcinoma, a common kidney cancer, show they did not have accelerated tumor growth after treatment with sunitinib, in contrast to some study results in animals. Sunitinib is one of several drugs, either on the market or undergoing testing, that target blood vessel growth.
› Verified 6 days ago